Payment overview · 2025
General Payments
$31.99
1 reported records · 1 companies
Healthcare provider profile · identity verified
Alba Pumarol, MD
Allopathic & Osteopathic Physicians|Family Medicine · BRONX, NY · NPI 1144220344
Verified facts
What the public records show
CMS Open Payments records show Alba Pumarol, MD received $31.99 in general payments during 2025 across 1 reported records.
Intra-Sana Laboratories accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 3 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Intra-Sana Laboratories | Unresolved — no canonical attribution shown | $31.99 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $31.99 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| GLYCATE Normalized: glycate |
Drug | Intra-Sana Laboratories | $31.99 | 1 | 2025 |
Source payment records
|
|||||
| RELTONE 200 MG Normalized: reltone 200 mg |
Drug | Intra-Sana Laboratories | $31.99 | 1 | 2025 |
Source payment records
|
|||||
| RELTONE 400 MG Normalized: reltone 400 mg |
Drug | Intra-Sana Laboratories | $31.99 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 523 | 129 |
| Jardiance | Empagliflozin | 237 | 48 |
| Metformin Hcl | Metformin Hcl | 228 | 44 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 214 | 42 |
| Amlodipine Besylate | Amlodipine Besylate | 200 | 55 |
| Omeprazole | Omeprazole | 195 | 39 |
| Lisinopril | Lisinopril | 186 | 49 |
| Nifedipine Er | Nifedipine | 149 | 35 |
| Fluticasone Propionate | Fluticasone Propionate | 146 | 33 |
| Metoprolol Succinate | Metoprolol Succinate | 138 | 33 |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 137 | 27 |
| Gabapentin | Gabapentin | 121 | 37 |
| Levothyroxine Sodium | Levothyroxine Sodium | 116 | 26 |
| Trulicity | Dulaglutide | 109 | 16 |
| Losartan Potassium | Losartan Potassium | 108 | 27 |
| Alendronate Sodium | Alendronate Sodium | 101 | 18 |
| Hydrochlorothiazide | Hydrochlorothiazide | 97 | 24 |
| Simvastatin | Simvastatin | 97 | 20 |
| Famotidine | Famotidine | 85 | 21 |
| Januvia | Sitagliptin Phosphate | 85 | 17 |
| Meclizine Hcl | Meclizine Hcl | 78 | 22 |
| Montelukast Sodium | Montelukast Sodium | 78 | 18 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 75 | 16 |
| Tamsulosin Hcl | Tamsulosin Hcl | 73 | 19 |
| Metformin Hcl Er | Metformin Hcl | 72 | 16 |
| Ozempic | Semaglutide | 71 | 15 |
| Novolog Flexpen | Insulin Aspart | 64 | 12 |
| Carvedilol | Carvedilol | 61 | suppressed |
| Eliquis | Apixaban | 61 | 13 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 56 | 14 |
| Diclofenac Sodium | Diclofenac Sodium | 55 | 13 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 55 | 16 |
| Alcohol Prep Pads | Alcohol Antiseptic Pads | 52 | 20 |
| Trazodone Hcl | Trazodone Hcl | 52 | suppressed |
| Ammonium Lactate | Ammonium Lactate | 51 | 11 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 50 | 21 |
| Ibuprofen | Ibuprofen | 49 | 15 |
| Cromolyn Sodium | Cromolyn Sodium | 48 | 12 |
| Farxiga | Dapagliflozin Propanediol | 47 | suppressed |
| Clopidogrel | Clopidogrel Bisulfate | 46 | 11 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 46 | suppressed |
| Chlorthalidone | Chlorthalidone | 44 | suppressed |
| Fenofibrate | Fenofibrate | 42 | suppressed |
| Furosemide | Furosemide | 40 | suppressed |
| Single Use Swab | Alcohol Antiseptic Pads | 40 | 17 |
| Hydrocortisone | Hydrocortisone | 37 | suppressed |
| Pantoprazole Sodium | Pantoprazole Sodium | 37 | suppressed |
| Metoprolol Tartrate | Metoprolol Tartrate | 36 | suppressed |
| Finasteride | Finasteride | 34 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 34 | suppressed |
| Ultra-Fine Nano Pen Needle | Pen Needle, Diabetic | 34 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 33 | suppressed |
| Atenolol | Atenolol | 33 | suppressed |
| Levetiracetam | Levetiracetam | 32 | suppressed |
| Sertraline Hcl | Sertraline Hcl | 32 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 31 | suppressed |
| Memantine Hcl | Memantine Hcl | 31 | suppressed |
| Spironolactone | Spironolactone | 31 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 30 | suppressed |
| Tradjenta | Linagliptin | 29 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 29 | 11 |
| Comfort Ez Pen Needle | Pen Needle, Diabetic | 27 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 27 | suppressed |
| Timolol Maleate | Timolol Maleate | 26 | suppressed |
| Latanoprost | Latanoprost | 25 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 24 | suppressed |
| Valsartan | Valsartan | 24 | suppressed |
| Lovastatin | Lovastatin | 23 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 21 | suppressed |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 20 | 15 |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 20 | suppressed |
| Ezetimibe | Ezetimibe | 19 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 19 | suppressed |
| Advair Diskus | Fluticasone Propion/Salmeterol | 18 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 18 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 18 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 18 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 18 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 18 | suppressed |
| Ranolazine Er | Ranolazine | 18 | suppressed |
| True Comfort Pro Alcohol Pads | Alcohol Antiseptic Pads | 18 | suppressed |
| Mirtazapine | Mirtazapine | 17 | suppressed |
| Nitroglycerin | Nitroglycerin | 17 | suppressed |
| Ondansetron Odt | Ondansetron | 17 | suppressed |
| Betamethasone Dipropionate | Betamethasone Dipropionate | 16 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 16 | suppressed |
| Irbesartan | Irbesartan | 16 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 16 | suppressed |
| Nystatin | Nystatin | 16 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 15 | suppressed |
| Entresto | Sacubitril/Valsartan | 15 | suppressed |
| Lansoprazole | Lansoprazole | 15 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 15 | suppressed |
| Allopurinol | Allopurinol | 14 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 14 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 14 | suppressed |
| Clotrimazole | Clotrimazole | 13 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 13 | suppressed |
| Meloxicam | Meloxicam | 13 | suppressed |
| Mupirocin | Mupirocin | 13 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 13 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 12 | suppressed |
| Celecoxib | Celecoxib | 12 | suppressed |
| Dorzolamide Hcl | Dorzolamide Hcl | 12 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 12 | suppressed |
| Glycopyrrolate | Glycopyrrolate | 12 | suppressed |
| Pregabalin | Pregabalin | 12 | suppressed |
| Ramipril | Ramipril | 12 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 11 | suppressed |
| Creon | Lipase/Protease/Amylase | 11 | suppressed |
| Fosinopril Sodium | Fosinopril Sodium | 11 | suppressed |
| Glimepiride | Glimepiride | 11 | suppressed |
| Repaglinide | Repaglinide | 11 | suppressed |
| Rivastigmine | Rivastigmine | 11 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 11 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 11 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $31.99 · 1 records | Intra-Sana Laboratories | GLYCATE, RELTONE 200 MG, RELTONE 400 MG | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error